Added to YB: 2016-05-19
Pitch date: 2016-05-19
MEIP [bullish]
Lite Strategy, Inc.
-95.9%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.
Market Cap
$55.9M
Pitch Price
$33.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.03
P/E
-1.62
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
MEI Pharma, Inc. MEIP
A summary for this pitch has not been created yet.
Read full article (0 min)